G
G Barosi
Researcher at University of Pavia
Publications - 19
Citations - 1853
G Barosi is an academic researcher from University of Pavia. The author has contributed to research in topics: International Prognostic Scoring System & Transplantation. The author has an hindex of 13, co-authored 19 publications receiving 1598 citations.
Papers
More filters
Journal ArticleDOI
Mutations and prognosis in primary myelofibrosis
Alessandro M. Vannucchi,Tl Lasho,Paola Guglielmelli,Flavia Biamonte,Animesh Pardanani,Arturo Pereira,Christy Finke,Joannah Score,Naseema Gangat,Carmela Mannarelli,Rp Ketterling,Giada Rotunno,Ra Knudson,Mc Susini,Rr Laborde,Ambra Spolverini,Alessandro Pancrazzi,Lisa Pieri,Rossella Manfredini,Enrico Tagliafico,Roberta Zini,Amy V. Jones,Katerina Zoi,Andreas Reiter,Andrew S Duncombe,Daniela Pietra,Elisa Rumi,Francisco Cervantes,G Barosi,Mario Cazzola,Nc Cross,Ayalew Tefferi +31 more
TL;DR: Mutational profiling for ASXL1, EZH2, SRSF2 and IDH identifies PMF patients who are at risk for premature death or leukemic transformation.
Journal ArticleDOI
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.
Kröger N,J. H. Deeg,Eduardo Olavarria,Dietger Niederwieser,Almalina Bacigalupo,T Barbui,Alessandro Rambaldi,Ruben A. Mesa,Ayalew Tefferi,Martin Griesshammer,Vikas Gupta,Claire N. Harrison,Haefaa Alchalby,Alessandro M. Vannucchi,Francisco Cervantes,Marie Robin,Markus Ditschkowski,Veena Fauble,Donal P. McLornan,Karen K. Ballen,Uday R. Popat,Francesco Passamonti,Damiano Rondelli,G Barosi +23 more
TL;DR: In this article, a comprehensive systematic review of articles released from 1999 to 2015 (January) was used as a source of scientific evidence to produce recommendations on the management of allogeneic stem cell transplantation in primary myelofibrosis (PMF).
Journal ArticleDOI
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
Daniela Pietra,Elisa Rumi,Virginia Valeria Ferretti,C. A. Di Buduo,Chiara Milanesi,Chiara Cavalloni,Emanuela Sant'Antonio,Vittorio Abbonante,Francesco Moccia,Ilaria Carola Casetti,Marta Bellini,Maria C. Renna,Elisa Roncoroni,Elena Fugazza,Cesare Astori,Emanuela Boveri,Vittorio Rosti,G Barosi,Alessandra Balduini,Alessandra Balduini,Mario Cazzola +20 more
TL;DR: Mutation subtype contributes to determining clinical phenotype and outcomes in CALR-mutant myeloproliferative neoplasms, and CALR variants that markedly impair the calcium binding activity of mutant calreticulin are mainly associated with a myelofibrosis phenotype.
Journal ArticleDOI
Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Mario Cazzola,Luisa Ponchio,F De Benedetti,Angelo Ravelli,Vittorio Rosti,Yves Beguin,Rosangela Invernizzi,G Barosi,Alberto Martini +8 more
TL;DR: Although oral iron is of no benefit, intravenous iron saccharate is a safe and effective means for improving iron availability for erythropoiesis and correcting this anemia.
Journal ArticleDOI
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type.
Almalina Bacigalupo,M Soraru,Alida Dominietto,Simonetta Pozzi,Simona Geroldi,M. T. Van Lint,Adalberto Ibatici,A M Raiola,Francesco Frassoni,F. De Stefano,Simonetta Verdiani,L. Casarino,G Barosi +12 more
TL;DR: PMF patients undergoing an allogeneic HSCT may be scored according to the spleen size, transfusion history and donor type; this scoring system may be useful to discuss transplant strategies.